NO996107L - C-4"-substituerte makrolidderivater - Google Patents

C-4"-substituerte makrolidderivater

Info

Publication number
NO996107L
NO996107L NO996107A NO996107A NO996107L NO 996107 L NO996107 L NO 996107L NO 996107 A NO996107 A NO 996107A NO 996107 A NO996107 A NO 996107A NO 996107 L NO996107 L NO 996107L
Authority
NO
Norway
Prior art keywords
macrolide derivatives
substituted macrolide
substituted
derivatives
macrolide
Prior art date
Application number
NO996107A
Other languages
English (en)
Other versions
NO315560B1 (no
NO996107D0 (no
Inventor
Brian Scott Bronk
Takushi Kaneko
Michael Anthony Letavic
Hengmiao Cheng
Edward Alan Glazer
Bingwei Vera Yang
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO996107D0 publication Critical patent/NO996107D0/no
Publication of NO996107L publication Critical patent/NO996107L/no
Publication of NO315560B1 publication Critical patent/NO315560B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19996107A 1997-06-11 1999-12-10 C-4"-substituerte makrolidderivater og fremgangsmåte for fremstilling derav, samt farmasöytisk blanding NO315560B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11
PCT/IB1998/000799 WO1998056801A1 (en) 1997-06-11 1998-05-25 C-4''-substituted macrolide derivatives

Publications (3)

Publication Number Publication Date
NO996107D0 NO996107D0 (no) 1999-12-10
NO996107L true NO996107L (no) 2000-02-10
NO315560B1 NO315560B1 (no) 2003-09-22

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996107A NO315560B1 (no) 1997-06-11 1999-12-10 C-4"-substituerte makrolidderivater og fremgangsmåte for fremstilling derav, samt farmasöytisk blanding

Country Status (40)

Country Link
EP (1) EP0988309B1 (no)
JP (1) JP3262806B2 (no)
KR (1) KR100369959B1 (no)
CN (1) CN1145636C (no)
AP (1) AP1189A (no)
AR (1) AR013085A1 (no)
AT (1) ATE310742T1 (no)
AU (1) AU745006C (no)
BG (1) BG64357B1 (no)
BR (1) BR9810097A (no)
CA (1) CA2293397C (no)
CO (1) CO4950584A1 (no)
DE (1) DE69832486T2 (no)
DZ (1) DZ2515A1 (no)
EA (1) EA002440B1 (no)
ES (1) ES2251081T3 (no)
GT (1) GT199800075A (no)
HK (1) HK1025974A1 (no)
HN (1) HN1998000074A (no)
HR (1) HRP980315A2 (no)
HU (1) HUP0004076A3 (no)
ID (1) ID24530A (no)
IL (1) IL132808A (no)
IS (1) IS1979B (no)
MA (1) MA24563A1 (no)
MY (1) MY133027A (no)
NO (1) NO315560B1 (no)
NZ (1) NZ500652A (no)
OA (1) OA11226A (no)
PA (1) PA8452001A1 (no)
PE (1) PE79999A1 (no)
PL (1) PL337497A1 (no)
SK (1) SK168299A3 (no)
TN (1) TNSN98084A1 (no)
TW (2) TWI224106B (no)
UA (1) UA70298A (no)
UY (1) UY25041A1 (no)
WO (1) WO1998056801A1 (no)
YU (1) YU62999A (no)
ZA (1) ZA985016B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1011689T3 (da) * 1997-09-10 2007-05-21 Merial Ltd Anvendelse af 9a-azalider som veterinære antimikrobielle midler
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
KR20010083944A (ko) 1998-11-03 2001-09-03 실버스타인 아써 에이. 신규 마크롤라이드 항생물질
CA2292359C (en) * 1999-01-28 2004-09-28 Pfizer Products Inc. Novel azalides and methods of making same
ES2256030T3 (es) * 1999-08-24 2006-07-16 Abbott Laboratories 9a-azalidas con actividad antibacteriana.
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
NZ518665A (en) * 2000-01-27 2005-02-25 Pfizer Prod Inc Azalide antibiotic compositions
EP1383780A1 (en) * 2001-04-27 2004-01-28 Pfizer Products Inc. Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
ATE429441T1 (de) 2002-07-08 2009-05-15 Glaxosmithkline Zagreb Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
AU2003255849A1 (en) * 2002-07-08 2004-01-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
AU2003255851B2 (en) 2002-07-08 2009-07-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
EP2772254A3 (en) * 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Novel Antibacterial Agents
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
EP2177526A4 (en) 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド系抗菌剤の調製プロセス
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 ４員環構造を有する１０ａ−アザライド化合物
CN105616437A (zh) 2008-10-24 2016-06-01 森普拉制药公司 使用含***的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US8940880B2 (en) * 2010-09-20 2015-01-27 Novartis Ag Process for the preparation of 9-deoxo-9a-homoerythromycin A, modified in the C-4″ of the cladinose ring by an epoxide group
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
EP2988597B1 (en) 2013-04-04 2022-06-08 President and Fellows of Harvard College Macrolides and methods of their preparation and use
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ １４員ケトライドならびにそれらの調製および使用の方法
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
KR20010013633A (ko) 2001-02-26
ES2251081T3 (es) 2006-04-16
DE69832486D1 (de) 2005-12-29
CN1259955A (zh) 2000-07-12
UA70298C2 (uk) 2004-10-15
YU62999A (sh) 2002-10-18
BG103969A (en) 2000-07-31
JP2000514097A (ja) 2000-10-24
UA70298A (uk) 2004-10-15
MY133027A (en) 2007-10-31
PA8452001A1 (es) 2000-05-24
DZ2515A1 (fr) 2003-02-01
CN1145636C (zh) 2004-04-14
EP0988309A1 (en) 2000-03-29
TW200418871A (en) 2004-10-01
PL337497A1 (en) 2000-08-28
JP3262806B2 (ja) 2002-03-04
UY25041A1 (es) 2000-09-29
CA2293397C (en) 2004-08-31
AP9801254A0 (en) 1998-06-30
IS5250A (is) 1999-11-16
EP0988309B1 (en) 2005-11-23
GT199800075A (es) 1999-11-30
AU745006B2 (en) 2002-03-07
HRP980315A2 (en) 1999-04-30
NO315560B1 (no) 2003-09-22
CA2293397A1 (en) 1998-12-17
AP1189A (en) 2003-07-16
HN1998000074A (es) 1999-01-08
CO4950584A1 (es) 2000-09-01
IL132808A (en) 2004-08-31
BR9810097A (pt) 2000-08-08
IL132808A0 (en) 2001-03-19
NZ500652A (en) 2001-10-26
EA002440B1 (ru) 2002-04-25
AU7228198A (en) 1998-12-30
HUP0004076A3 (en) 2003-05-28
NO996107D0 (no) 1999-12-10
AR013085A1 (es) 2000-12-13
ZA985016B (en) 1999-12-10
IS1979B (is) 2005-01-14
PE79999A1 (es) 1999-08-25
HK1025974A1 (en) 2000-12-01
KR100369959B1 (ko) 2003-02-12
MA24563A1 (fr) 1998-12-31
TNSN98084A1 (fr) 2005-03-15
OA11226A (en) 2003-07-16
WO1998056801A1 (en) 1998-12-17
ATE310742T1 (de) 2005-12-15
ID24530A (id) 2000-07-20
BG64357B1 (bg) 2004-11-30
HUP0004076A2 (hu) 2001-04-28
EA199901014A1 (ru) 2000-06-26
SK168299A3 (en) 2000-09-12
DE69832486T2 (de) 2006-07-27
AU745006C (en) 2006-02-23
TWI224106B (en) 2004-11-21

Similar Documents

Publication Publication Date Title
NO996107D0 (no) C-4"-substituerte makrolidederivater
NL300150I1 (nl) 4"-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
NO983169L (no) Hetrosykel-kondenserte morfinoidderivater (31)
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
IS5251A (is) 9-oxím erýþrómýsín afleiður
ATE377018T1 (de) Erythromycinderivate
DE69718771T2 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
ATE231508T1 (de) Azyklische nukleosidderivate
DK1032579T3 (da) Carbohydratderivater
LV11898A (lv) Eritromicina atvasinajumi
ATE215547T1 (de) Kohlerhydratderivate
PT1060183E (pt) Derivados de 5'-desoxicitidina
DK1077984T3 (da) 2'-Deoxyhygromycin derivater
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
BR1100649A (pt) Derivados de 10,11-metano dibenzo suberano